SecurityScorecard gave healthcare a “B+” in cybersecurity, but some healthcare organizations had low ratings despite the group concluding that ratings were “higher than expected.” I tend to think that ratings are a bit inflated, but nonetheless it is a good service for the nation.
#cyberattacks #healthcare
The Supreme Court declined to hear a case challenging the anti-trust settlement between the federal government and BCBS plans nationwide. While no wrongdoing was admitted, BCBS plans were accused of anti-competitive behavior in the employer market because it limited employers to contracting with BCBS entities in their headquarters’ area and required a threshold for Blues revenue.
The appeals court argued the settlement does not preclude future actions. The high court agreed. Several employers argued the settlement was not enough and that it did preclude certain actions over time. I will be writing about this soon. While the settlement was somewhat of a defeat for the Blues and its association, it actually tends to underscore the anti-competitive aspects of the broader healthcare market and protects the Blues.
Additional articles: https://www.modernhealthcare.com/legal/supreme-court-bcbs-settlement-home-depot and https://www.beckerspayer.com/payer/supreme-court-rejects-home-depots-challenge-to-2-7b-bcbs-settlement.html
(Some articles may require a subscription.)
#bcbsa #blues #healthcare #coverage #employercoverage
https://www.fiercehealthcare.com/payers/supreme-court-declines-hear-challenge-27b-bcbs-settlement
A Federal Appeals Court issued a mixed-bag ruling on whether free preventive services will continue in the Affordable Care Act (ACA). It upheld a lower court ruling finding that the government could not compel a Christian-based business to cover certain services that violate its religious beliefs. At the same time, it struck down the lower court’s bar on enforcement of preventive services nationwide and returned the future of the preventive services mandate back to a lower court.
Additional article: https://thehill.com/policy/healthcare/4733629-obamacare-preventive-care-mandate-to-stay-in-place-after-court-ruling/
#aca #obamacare #exchanges #healthcare #coverage #healthcarereform
Change Healthcare began reaching out to clients who had data compromised in the ransomware attack and breach that brought much of the healthcare system to a standstill earlier this year. Compromised data includes personal and health information. The breach hit a substantial portion of Americans.
An additional article points to the great vulnerability of hospitals to cyberattacks.
Additional articles: https://kffhealthnews.org/news/article/hospitals-cyberattacks-ascension-patient-care/ and https://www.modernhealthcare.com/cybersecurity/change-healthcare-data-breach-cyberattack-notification
(Some articles may require a subscription.)
#changehealthcare #cyberattacks
https://www.fiercehealthcare.com/payers/optums-change-healthcare-responding-cybersecurity-issue
A Modern Healthcare article speaks to the fact that highly rated Medicare Advantage plans could lose billions in Star dollars if a change to the hold harmless provision for the quality improvement measures is changed. I will have a LinkedIn post tomorrow on this and other changes the Centers for Medicare and Medicaid Services (CMS) could make to save dollars.
(Article may require a subscription.)
#medicareadvantage #stars #cms
https://www.modernhealthcare.com/insurance/medicare-advantage-star-ratings-centene-molina-bonuses
Two major developments in the direct-to-consumer pharmacy market. A study published in the JAMA Health Forum suggests that most people that are insured are better off going through their insurance than through Mark Cuban’s Cost Plus Drug Company, although some deals are better for certain medications for the insured and those uninsured benefit. I am not sure the purpose of the story. Of course, insurance should be a better deal than not going through insurance. But the fact is that often Cuban’s outfit can offer better deals due to the opaqueness of the drug supply channel. The fact that 100 million of 844 million prescription fills (of 124 generic drugs) would have been cheaper under Cuban’s paradigm than insurance proves the system needs reform. Cuban is on to something.
In other news, Amazon Pharmacy has extended Amazon Pharmacy Rx Pass membership to Medicare enrollees. RxPass subscribers pay $5 a month to fill as many prescriptions as needed from a list of about 60 generic medications, including delivery to their doorstep.
Additional articles: https://www.fiercehealthcare.com/payers/mark-cubans-d2c-pharmacy-wont-beat-most-insured-patients-out-pocket-drug-prices-study-finds and https://thehill.com/policy/technology/4727072-amazon-pharmacy-expands-medicare-rxpass/
#drugpricing #cuban #pbms
https://www.healthcaredive.com/news/amazon-rxpass-medicare-generic-drug-subscription/719231
Scan CEO Sachin Jain, MD is one of the brightest minds in healthcare. He has the right outlook on Medicare Advantage (MA) – it does a lot that is good but also needs reform. In addition, he rightfully is asking why the traditional fee-for-service (FFS) program does not face reasonable scrutiny for its over-utilization.
#scan #medicare #medicareadvantage
https://www.fiercehealthcare.com/payers/ahip-2024-cutting-through-nostalgia-traditional-medicare
A new study says the Federal Trade Commission’s (FTC) scrutiny of mergers is low and mergers lead to increased prices. Part of the issue is low funding for the FTC.
(Article may require a subscription.)
#ftc #manda #mergers #acquisitions #hospitals
After losing two lawsuits on their methodology, the Centers for Medicare and Medicaid Services announced it has recalculated 2024 Star measures for Medicare Advantage (MA) plans. It will give plans that saw increases a short window to revise 2025 plan bids and benefits that have already been submitted.
Additional article here: https://insidehealthpolicy.com/daily-news/scan-cms-recalculate-ma-star-ratings-rebidding-process-come
(Some articles may require a subscription.)
#medicareadvantage #stars #cms
https://www.beckerspayer.com/payer/cms-to-recalculate-medicare-advantage-star-ratings-report.html
The Centers for Medicare & Medicaid Services (CMS) Office of the Actuary released its annual re-estimates of spending over a 10-year horizon. While 2023 healthcare expenditures will be finalized in December, current estimates are that national healthcare spending grew by 7.5% in 2023 to about $4.8 trillion, or 17.6% of gross domestic product (GDP). Part of the costs were record coverage.
Medicare spending is projected to have grown 8.4% in 2023, with costs over $1 trillion. Private health insurance spending is expected to have increased 11.1%. Medicaid spending is expected to have grown by 5.7%. This is lower due to dropping enrollment.
National health expenditures will rise to $7.7 trillion and capture nearly one-fifth of the U.S. economy by 2032.
I will have a blog next week digging into all the stats.
Additional articles: https://www.modernhealthcare.com/policy/national-health-spending-projected-reach-77t-2032-cms and https://www.healthcaredive.com/news/national-healthcare-spending-growth-cms-report/718718/ and https://www.cms.gov/newsroom/press-releases/cms-releases-2023-2032-national-health-expenditure-projections
(Some articles may require a subscription.)
#healthcare #costs
https://www.fiercehealthcare.com/finance/cms-projects-national-health-spending-grew-75-2023-48t
